Drug Delivery Devices Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

Global Drug Delivery Devices Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Drug Delivery Devices Market Over The Period 2026–2030?

The drug delivery devices market has experienced robust expansion in recent times. This market is projected to expand from $95.99 billion in 2025 to $102.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this growth can be linked to the increasing prevalence of chronic diseases, the expansion of injectable therapies, the growth in hospital-based drug administration, the increasing use of infusion devices, and advancements in pharmaceutical formulations.

The market for drug delivery devices is projected to experience robust expansion over the coming years. It will grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. This growth during the projected timeframe stems from factors such as the greater acceptance of home-based drug delivery, escalating investments in personalized medicine, the expanding presence of biologics and biosimilars, the rising need for connected delivery devices, and the increasing incorporation of digital health platforms. Key trends identified for the forecast period encompass the increasing widespread use of smart drug delivery devices, a surge in the utilization of self-administration injection systems, an expanding requirement for controlled release technologies, the growth of wearable drug delivery platforms, and a heightened emphasis on designs centered around the patient.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Drivers Are Expected To Influence The Drug Delivery Devices Market During The Forecast Period?

The anticipated rise in healthcare expenditure is set to drive expansion within the drug delivery devices market. This expenditure encompasses the entire financial outlay on health-related services and products, covering costs for hospitals, doctors, nursing, pharmaceutical drugs, and public health initiatives. The increase in healthcare spending stems from factors such as an aging demographic, the growing occurrence of chronic illnesses, innovations in medical technology, and elevated expenses for medical services and prescription medications. Greater investment in healthcare fosters the development of drug delivery devices by channeling more capital into research, pioneering new solutions, and implementing cutting-edge technologies that enhance treatment effectiveness and patient results. For example, data released in May 2024 by the Office for National Statistics, a UK government body, indicated that UK healthcare spending hit approximately $379 billion (£292 billion) in 2023. This figure represented a nominal surge of 5.6% compared to 2022, a substantial increase from the 0.9% growth recorded in 2023. Consequently, the expanding healthcare expenditure is a key factor propelling the growth of the drug delivery devices market.

How Is The Drug Delivery Devices Market Divided Into Its Major Segments?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

How Are Trends Transforming The Drug Delivery Devices Market Landscape?

Companies prominent in the drug delivery devices market are concentrating on developing advanced solutions, such as targeted oral release capsules, to boost treatment efficacy and lessen systemic side effects. These targeted oral release capsules are specifically engineered to withstand the acidic environment of the stomach and precisely release active ingredients into particular segments of the gastrointestinal tract, thereby enhancing bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, introduced its new EUDRACAP colon capsules, designed for the delivery of sensitive active substances to the ileo-colonic region. These capsules support the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides, while preserving their integrity through tailored EUDRAGIT coatings. The EUDRACAP colon capsules also streamline formulation development with a ready-to-fill design and improve speed to market by reducing developmental complexity. This innovation expands Evonik’s EUDRACAP platform and reinforces its system solutions portfolio for advanced oral drug delivery.

Who Are The Prominent Organizations Shaping The Drug Delivery Devices Market?

Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero

Read the full drug delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which Region Is Forecast To Lead The Drug Delivery Devices Market In Terms Of Market Size?

North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2026, By The Business Research Company

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Connected Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model